Matches in SemOpenAlex for { <https://semopenalex.org/work/W4312085209> ?p ?o ?g. }
- W4312085209 endingPage "114105" @default.
- W4312085209 startingPage "114105" @default.
- W4312085209 abstract "Alzheimer's disease (AD) is the most common dementia characterized by the excessive accumulation of amyloid-beta (Aβ) and tau aggregates, as well as neuronal damage and neuroinflammation. Metabolic disruption in AD has been noticed because metabolite alterations closely correlate with Aβ neuropathology and behavioral phenotypes. Accordingly, controlling various neuropathological processes and metabolic disruption is an efficient therapeutic strategy for AD treatment. In this study, we evaluated the effects of a combination of Cuscuta seeds and Lactobacillus paracasei NK112 (CCL01) on AD neuropathology and altered metabolism in five familial AD (5xFAD) transgenic mice and neuronal cell cultures. First, we observed that CCL01 exerted neuroprotective effects in HT22 hippocampal neurons and primary cultured neurons. CCL01 ameliorated memory decline and protected synapses and neuronal survival in 5xFAD mice. These effects were related to the inhibition of tau phosphorylation. CCL01 also inhibited the activation of mitogen-activated protein kinase (MAPK) signaling and neuroinflammatory processes. Moreover, the metabolite profile-particularly characterized by altered phospholipid metabolism-was significantly changed in the 5xFAD group, while CCL01 partly restored the alteration. Lysophosphatidylcholine (lysoPC), the levels of which were higher in the brains of 5xFAD mice, exerted neurotoxicity in vitro, whereas CCL01 protected neurons from lysoPC-induced toxicity by regulating MAPK signaling. Additionally, CCL01 administration reduced gut inflammation in the 5xFAD mice. In summary, we demonstrated that CCL01 improved the memory function of 5xFAD mice by protecting neurons against Aβ- and lysoPC-induced toxicity through the regulation of MAPK signaling, neuroinflammation, tau phosphorylation, and gut inflammation, suggesting the potential of CCL01 as treatment for AD." @default.
- W4312085209 created "2023-01-04" @default.
- W4312085209 creator A5002179767 @default.
- W4312085209 creator A5006407218 @default.
- W4312085209 creator A5009751973 @default.
- W4312085209 creator A5012503420 @default.
- W4312085209 creator A5015260584 @default.
- W4312085209 creator A5020474906 @default.
- W4312085209 creator A5041899584 @default.
- W4312085209 creator A5049214550 @default.
- W4312085209 creator A5052946793 @default.
- W4312085209 creator A5067591209 @default.
- W4312085209 creator A5082325472 @default.
- W4312085209 creator A5085660248 @default.
- W4312085209 creator A5086613530 @default.
- W4312085209 date "2023-02-01" @default.
- W4312085209 modified "2023-09-26" @default.
- W4312085209 title "Protective effects of CCL01 against Aβ-induced neurotoxicity in 5xFAD transgenic mouse model of Alzheimer's disease" @default.
- W4312085209 cites W1966739013 @default.
- W4312085209 cites W1968602836 @default.
- W4312085209 cites W1972886222 @default.
- W4312085209 cites W1973296024 @default.
- W4312085209 cites W1990752558 @default.
- W4312085209 cites W1991623690 @default.
- W4312085209 cites W1999970418 @default.
- W4312085209 cites W2025639892 @default.
- W4312085209 cites W2042017613 @default.
- W4312085209 cites W2043085415 @default.
- W4312085209 cites W2074526001 @default.
- W4312085209 cites W2077555085 @default.
- W4312085209 cites W2077600892 @default.
- W4312085209 cites W2087243986 @default.
- W4312085209 cites W2111200377 @default.
- W4312085209 cites W2130273669 @default.
- W4312085209 cites W2164390570 @default.
- W4312085209 cites W2346000952 @default.
- W4312085209 cites W2383561113 @default.
- W4312085209 cites W2403440517 @default.
- W4312085209 cites W2462234872 @default.
- W4312085209 cites W2558063058 @default.
- W4312085209 cites W2625490249 @default.
- W4312085209 cites W2626091936 @default.
- W4312085209 cites W2725377723 @default.
- W4312085209 cites W2734651019 @default.
- W4312085209 cites W2741158638 @default.
- W4312085209 cites W2802395419 @default.
- W4312085209 cites W2808028315 @default.
- W4312085209 cites W2889774924 @default.
- W4312085209 cites W2891359652 @default.
- W4312085209 cites W2900648689 @default.
- W4312085209 cites W2901221619 @default.
- W4312085209 cites W2916685682 @default.
- W4312085209 cites W2919002166 @default.
- W4312085209 cites W2967026120 @default.
- W4312085209 cites W2967456298 @default.
- W4312085209 cites W2976163884 @default.
- W4312085209 cites W2981934403 @default.
- W4312085209 cites W2998789945 @default.
- W4312085209 cites W3005183050 @default.
- W4312085209 cites W3006131455 @default.
- W4312085209 cites W3009210840 @default.
- W4312085209 cites W3017386351 @default.
- W4312085209 cites W3024429795 @default.
- W4312085209 cites W3034639723 @default.
- W4312085209 cites W3036226369 @default.
- W4312085209 cites W3038957615 @default.
- W4312085209 cites W3048109944 @default.
- W4312085209 cites W3081705835 @default.
- W4312085209 cites W3090273996 @default.
- W4312085209 cites W3093492766 @default.
- W4312085209 cites W3098019302 @default.
- W4312085209 cites W3120005181 @default.
- W4312085209 cites W3123956652 @default.
- W4312085209 cites W3179732585 @default.
- W4312085209 cites W3199994427 @default.
- W4312085209 cites W3203556761 @default.
- W4312085209 cites W4200390523 @default.
- W4312085209 cites W4283364937 @default.
- W4312085209 cites W4313485166 @default.
- W4312085209 doi "https://doi.org/10.1016/j.biopha.2022.114105" @default.
- W4312085209 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36508997" @default.
- W4312085209 hasPublicationYear "2023" @default.
- W4312085209 type Work @default.
- W4312085209 citedByCount "1" @default.
- W4312085209 countsByYear W43120852092023 @default.
- W4312085209 crossrefType "journal-article" @default.
- W4312085209 hasAuthorship W4312085209A5002179767 @default.
- W4312085209 hasAuthorship W4312085209A5006407218 @default.
- W4312085209 hasAuthorship W4312085209A5009751973 @default.
- W4312085209 hasAuthorship W4312085209A5012503420 @default.
- W4312085209 hasAuthorship W4312085209A5015260584 @default.
- W4312085209 hasAuthorship W4312085209A5020474906 @default.
- W4312085209 hasAuthorship W4312085209A5041899584 @default.
- W4312085209 hasAuthorship W4312085209A5049214550 @default.
- W4312085209 hasAuthorship W4312085209A5052946793 @default.
- W4312085209 hasAuthorship W4312085209A5067591209 @default.
- W4312085209 hasAuthorship W4312085209A5082325472 @default.
- W4312085209 hasAuthorship W4312085209A5085660248 @default.